This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Saint Louis University, The City University of New York, The United States Government as Represented by the Department of Veterans Affairs. Active years: 2025.
Company Filing History:
1 out of 224 
1 out of 336 
1 out of 955 
Years Active: 2025
Title: Bahaa Elgendy: Innovator in Antibiotic Development
Introduction
Bahaa Elgendy is a notable inventor based in St. Louis, MO (US). He has made significant contributions to the field of antibiotic development, particularly through his innovative research on inhibitors of nucleotidyltransferase superfamily enzymes.
Latest Patents
Elgendy holds a patent for "Inhibitors of nucleotidyltransferase superfamily enzymes as antibiotics." This patent outlines methods for treating bacterial infections using specific inhibitors. The compounds described in the patent may include various formulas and can be utilized to combat infections caused by different bacterial species.
Career Highlights
Throughout his career, Bahaa Elgendy has worked with esteemed institutions, including Saint Louis University and the United States Government as represented by the Department of Veterans Affairs. His work has focused on developing novel therapeutic strategies to address bacterial infections.
Collaborations
Elgendy has collaborated with Feng Cao, contributing to advancements in his field. Their partnership has fostered innovative approaches to antibiotic research.
Conclusion
Bahaa Elgendy is a prominent figure in the development of antibiotic therapies, with a focus on nucleotidyltransferase inhibitors. His work continues to impact the medical field positively.